Plaimauer Barbara, Zimmermann Klaus, Völkel Dirk, Antoine Gerhard, Kerschbaumer Randolf, Jenab Pegah, Furlan Miha, Gerritsen Helen, Lämmle Bernhard, Schwarz Hans Peter, Scheiflinger Friedrich
Baxter BioScience, Biomedical Research Center, Orth, Austria.
Blood. 2002 Nov 15;100(10):3626-32. doi: 10.1182/blood-2002-05-1397. Epub 2002 Jul 12.
Deficient von Willebrand factor (VWF) degradation has been associated with thrombotic thrombocytopenic purpura (TTP). In hereditary TTP, the specific VWF-cleaving protease (VWF-cp) is absent or functionally defective, whereas in the nonfamilial, acquired form of TTP, an autoantibody inhibiting VWF-cp activity is found transiently in most patients. The gene encoding for VWF-cp has recently been identified as a member of the metalloprotease family and designated ADAMTS13, but the functional activity of the ADAMTS13 gene product has not been verified. To establish the functional activity of recombinant VWF-cp, we cloned the complete cDNA sequence in a eukaryotic expression vector and transiently expressed the encoded recombinant ADAMTS13 in HEK 293 cells. The expressed protein degraded VWF multimers and proteolytically cleaved VWF to the same fragments as those generated by plasma VWF-cp. Furthermore, recombinant ADAMTS13-mediated degradation of VWF multimers was entirely inhibited in the presence of plasma from a patient with acquired TTP. These data show that ADAMTS13 is responsible for the physiologic proteolytic degradation of VWF multimers.
血管性血友病因子(VWF)降解不足与血栓性血小板减少性紫癜(TTP)有关。在遗传性TTP中,特异性VWF裂解蛋白酶(VWF-cp)缺失或功能缺陷,而在非家族性、获得性TTP中,大多数患者会短暂发现抑制VWF-cp活性的自身抗体。编码VWF-cp的基因最近被确定为金属蛋白酶家族的成员,并命名为ADAMTS13,但ADAMTS13基因产物的功能活性尚未得到验证。为了确定重组VWF-cp的功能活性,我们将完整的cDNA序列克隆到真核表达载体中,并在HEK 293细胞中瞬时表达编码的重组ADAMTS13。表达的蛋白降解VWF多聚体,并将VWF蛋白水解切割成与血浆VWF-cp产生的片段相同的片段。此外,在获得性TTP患者的血浆存在的情况下,重组ADAMTS13介导的VWF多聚体降解被完全抑制。这些数据表明,ADAMTS13负责VWF多聚体的生理性蛋白水解降解。